Correlation Between Evolent Health and Anheuser-Busch InBev

Can any of the company-specific risk be diversified away by investing in both Evolent Health and Anheuser-Busch InBev at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evolent Health and Anheuser-Busch InBev into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Evolent Health and Anheuser Busch InBev SANV, you can compare the effects of market volatilities on Evolent Health and Anheuser-Busch InBev and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evolent Health with a short position of Anheuser-Busch InBev. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evolent Health and Anheuser-Busch InBev.

Diversification Opportunities for Evolent Health and Anheuser-Busch InBev

-0.66

Correlation Coefficient

Evolent Health  Anheuser-Busch InBev

Excellent diversification

The 3 months correlation between Evolent and Anheuser-Busch is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Evolent Health and Anheuser Busch InBev SANV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anheuser Busch InBev and Evolent Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evolent Health are associated (or correlated) with Anheuser-Busch InBev. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anheuser Busch InBev has no effect on the direction of Evolent Health i.e., Evolent Health and Anheuser-Busch InBev go up and down completely randomly.

Pair Corralation between Evolent Health and Anheuser-Busch InBev

Assuming the 90 days horizon Evolent Health is expected to generate 5.58 times more return on investment than Anheuser-Busch InBev. However, Evolent Health is 5.58 times more volatile than Anheuser Busch InBev SANV. It trades about 0.03 of its potential returns per unit of risk. Anheuser Busch InBev SANV is currently generating about 0.04 per unit of risk. If you would invest  785.00  in Evolent Health on April 24, 2025 and sell it today you would earn a total of  25.00  from holding Evolent Health or generate 3.18% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.44%
Values	Daily Returns

Evolent Health  vs.  Anheuser Busch InBev SANV

Evolent Health

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Evolent Health are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Evolent Health may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Anheuser Busch InBev

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Anheuser Busch InBev SANV are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable fundamental drivers, Anheuser-Busch InBev is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Evolent Health and Anheuser-Busch InBev

The main advantage of trading using opposite Evolent Health and Anheuser-Busch InBev positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evolent Health position performs unexpectedly, Anheuser-Busch InBev can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anheuser-Busch InBev will offset losses from the drop in Anheuser-Busch InBev's long position.

The idea behind Evolent Health and Anheuser Busch InBev SANV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.